Statistics suggested that Christy’s odds of survival were grim, so she leaned into her faith and kept a positive outlook. She tried to control what she could. And, critically, she received biomarker testing.
It’s scary to hear the “c” word, especially when you’re only 36. A million questions ran through Gabriel Leblanc’s mind, but only one seemed to matter. “How was I going to get through this?” Gabriel said.
Michael Schnabel was determined to capture his daughter’s courage, strength, and love of life. He wanted to pass it on to her newborn son if she didn’t survive.
BlueHQ is the Colorectal Cancer Alliance’s new patient and caregiver support hub. BlueHQ makes it easy to find personalized support, without endless online searching.
Clinical trials can be life-changing. Learn how Kevin's participation in a Dana-Farber trial is helping him monitor colorectal cancer recurrence — and what it could mean for others.
When Helen was diagnosed with metastatic colorectal cancer, the biggest concern for her medical team was that her cancer had spread to her liver. One type of therapy, hepatic artery infusion, offered a path forward, but there was a catch. Nobody at her hospital had ever done it before. She'd have to be first.
For many cancer patients, the end of active treatment brings a new kind of dread. Scans every few months and anxious waits for results. A blood test is changing that experience for a growing number of patients.